[ 125 I]-N*-4-aminobenzyladenosine bound with a higher affinity to brain (K D = 1.93 iw) than to heart membranes (K D = 11.6 iw). At the radioligand KD, 60% of the total ['"I]-N*-4-aminobenzyladenosine bound to heart membranes was specifically bound. Iodination of aminobenzyladenosine increased its affinity for the adenosine receptor by 22-fold, possibly due to a steric or hydrophobic effect of iodine. The new ligand was found to be a full adenosine agonist based on its ability to inhibit cyclic adenosinemonophosphate accumulation in isolated embryonic chick heart cells and rat adipocytes. [ 125 I]-N*-4-Aminobenzyladenosine bound to a single affinity site and was displaced from cardiac and brain' adenosine receptors by other adenosine analogues with a potency order of /-phenylisopropyladenosine > 5'-N-ethylcarboxamide adenosine. These characteristics suggest that the radioligand binds to an Ri adenosine receptor. (Circ Res 56: 279-284, 1985) RADIOLIGAND binding to adenosine receptors in membranes derived from tissues rich in adenosine receptors (brain and testes) has been convincingly demonstrated using [ 3 H]cydohexyladenosine, /-[ 3 H]phenylisopropyladenosine, and [ 3 H]-2-chloroadenosine (reviewed by Daly, 1982) . Other adenosine radioligands which have been shown to bind to adenosine receptors include [ 3 H]-5'-N-ethylcarboxamide adenosine (Daly et al., 1979) , [ 3 H]diethylphenylxanthine (Yeung and Green, 1984) , and [ 125 I]hydroxyphenylisopropyladenosine (HPIA) (see Munshi and Baer, 1982; Schwabe et al., 1982; Linden, 1984) . Inotropic effects by adenosine and adenosine analogues on heart have been studied extensively (Shrader et al., 1977; Dobson, 1978; Belardinelli et al., 1982) , but it has been difficult to characterize adenosine receptors in heart membranes because the sparsity of receptors results in a high ratio of nonspecific to specific binding. Our initial attempts to measure adenosine receptors in heart membranes using tritiated compounds were only marginally successful. For the purposes of this study, two iodinated radioligands, /-[ 12 *I]HPIA and new compound [ 125 I]-N 6 -4-aminobenzyladenosine ([ 125 I]ABA), were tested as cardiac adenosine receptor radioligands. Both compounds bound specifically to adenosine receptors with similar K D 's in the nanomolar range, but the latter compound displayed one-sixth of the lower nonspecific binding and is therefore the more useful radioligand.
Methods

Synthesis of N*-4-Nitrobenzyladenosine
The N*-4-nitrobenzyl derivative of adenosine was prepared by a modification of the method of Fleysher et al. (1969) . Adenosine (10.7 g, 40 mmol) was added to 140 ml of dimethylformamide and stirred at 80°C under N 2 until a dear solution resulted. The solution was cooled to 21°C, and p-nitrobenzylbromide (25.92 g, 120 mmol; Aldrich) was added. After being stirred at room temperature under nitrogen for 24 hours, the resultant N 1 -substituted adenosine derivative was rearranged to the N'-substituted compound and crystallized. The structure of this and other compounds was confirmed by UV and NMR spectra.
Synthesis of N*-4-Aminobenzyladenosine (ABA)
N*-4-Nitrobenzyladenosine (NBA) (3.62K, 9 mmol) was dissolved in acetone and 10% NaOH (pH 10). Sodium dithionite (5.22 g, 30 mmol) was added, and the mixture was heated with stirring at 40-50°C for 1 hour. The product was cooled to room temperature and adjusted to pH 7-8 with HQ. The mixture was not allowed to become acidic, since hydrolysis in add leads to formation of the free base (Jones and Robins, 1963) . The product was extracted with ethyl acetate several times and dried by adding Na 2 SO«. After filtration, the product was concentrated and then crystallized by the addition of hexane and cooling to 4°C for 18 hours. The crystals were filtered, washed with ethyl acetate, and stored desiccated at -20°C.
HPLC Method for Purification of iV-Benzyladenoslne Derivatives
N*-Benzyladenosine derivatives were applied to a 4.5 X 20 mm octadecyl (C18) reverse phase column and eluted with chromatography buffer (MeOH/50 mM ammonium formate, pH 8; 1:1) isocratically at a flow rate of 1 ml/min using an IBM LC/9533. UV absorption of the eluate was monitored at 271 run. Fractions of the column eluate were collected at 30-second intervals using a Gilson 201 fraction collector. The fractions containing 125 I-labeled products were counted in a Beckman 5500 7-counter.
Preparative lodination of ABA
One milligram of ABA was dissolved in 2.5 ml of 0.3 N KH2PO4 (pH 7.5). To this solution, 0.25 ml of 10 mM KI and 10 jiCi Na 125 I (Amersham) were added, followed by 0.5 ml of chloramine T (2 mg/ml in H 2 O). After mixing for 60 seconds, the iodination reaction was stopped by the addition of 1 ml of sodium metabisulfite (10 mg/ml in H 2 O). The product was extracted five times with 0.5 ml of ethyl acetate. The pooled extracts, which contained 60% of the added radioactive iodide, were evaporated to dryness under nitrogen and dissolved in chromatography buffer. IABA was separated from ABA and I 2 ABA by HPLC, as described above. There was a 1:1 ratio of iodine to ABA in IABA based on the ratio of OD:tracer 12J I.
Synthesis of Carrier-Free p"I]ABA
One millicurie of Na 125 I, in 100 nl of 0.3 N KH 2 PO 4 (pH 7.5) was added to 100 iA of 0.1 mM ABA, followed by 5 /J of chloramine T (1 mg/ml in water). The mixture was mixed for 60 seconds, and the iodination reaction was stopped with 50 /xl of sodium metabisulfite (5 mg/ml in H 2 O). The products were extracted 5 times with 200 n\ of ethyl acetate, evaporated to dryness under N^ and dissolved in chromatography buffer. [ 125 I]ABA was purified by HPLC, as described above.
Radioligand Binding Assays
/-[ 12s I]Hydroxyphenylisopropyladenosine ([ 12i I]HPIA) synthesis, binding assays, and protein determinations were conducted as described by Linden (1984) . Equilibrium binding assays with either [ 123 I]ABA or [ 125 I]HPIA, were conducted for 2 hours at 21°C and terminated by filtration OVCT 25-mm glass fiber filters (Gelman A/E). Nonspecific binding was assessed by the addition of 0.1 mM Z-phenylisopropyladenosine (PIA). Membranes were preincubated with 1 U/ml of adenosine deaminase at 37°C for 20 minutes. Fifty microliters of membranes were added to 50 pi of radioligand prepared in Tris buffer (50 HIM Tris-Cl, 15 DIM MgCl^ and 0.1 mM EDTA, pH 7.3, at 25°C). The radioligand concentrations were held constant between 50 and 150 pM and diluted with various concentrations of unlabeled ligands between 0.1 and 25
Preparation of Membranes
Rat brains or heart ventricles were homogenized with a Polytron tissue disruptor in 25 volumes of ice-cold HEPES-sucrose buffer (mM): HEPES, 10; EDTA, 10; benzamide, 0.1; dithiothreitol, 1; sucrose, 292. The homogenates were centrifuged at 2,000 g for 20 minutes. The pellets were resuspended in 25 volumes of ice-cold sucrose-free HEPES buffer, incubated on ice for 15 minutes, and centrifuged at 20,000 g for 30 minutes. The final pellet was resuspended in five volumes of HEPES buffeT containing 20% glycerol and frozen at -70°C. The brain membranes were diluted 10-fold with HEPES buffer for binding assays, heart membranes were used undiluted. Glycerol slightly reduced the amount (20%) but had no effect on the affinity of radioligand binding.
Preparation of Adipocytes and Heart Cells
Epididymal fat pads from 200 to 300-g male Sprague-Dawley rats were minced in Eagle's spinner-modified minimal essential medium buffered with 10 mM Na-HEPES (pH 7.4) containing 1% bovine serum albumin and 1 mg/ml collagenase. After incubation at 37°C for 45 minutes in a shaker bath, loosely adherent cells were separated upon being pipetted through 250 fiM nylon mesh. The cells were resuspended in HEPES medium and maintained at 21°C until used. Ventricles obtained from 10-day-old embryonic white Leghorn chicks were dispersed in Ca"^-and Mg^-free phosphate-buffered saline containing 0.05% collagenase and 0.01% trypsin. Cells were harvested at 5-minute intervals. Cells were washed and maintained at 21°C in HEPES-buffered (10 mM, pH 7.4) Ham's F12 medium until used.
cAMP Measurements
Adipocytes and heart cells were incubated in a volume of 100 n\ with 1 U/ml adenosine deaminase, 1 mM Ro7-2956 (a phosphodiesterase inhibitor), 1 mM ascorbate, and in some cases adenosine analogues or 1 IM (-)-isoproterenol for 90 seconds at 37°C. Cells were lysed by the addition of 400 /J of 0.1 N HC1. Succinyl cAMP tryosyl methyl esteT was iodinated and purified by paper and anion exchange chromatography as described by Brooker et al. (1979) . Tissue extracts of cAMP were acetylated and assayed by Gammaflo automated radioimmunoassay (Brooker et al., 1976) .
Results and Discussion
Physical Properties of NBA, ABA, and IABA Alkylation of adenosine with p-nitrobenzylbromide gave the N'-substituted derivative which was rearranged in base to give the N 6 -substituted compound, NBA. Both NBA and its reduced products, ABA and IABA, could be readily resolved from each other by HPLC. The UV absorption spectra of NBA and ABA agreed with previously published results (Table 1) . NMR confirming the structures of ABA and IABA are illustrated in Figure 1 . (57 fig protein) or heart (403 tig protein) membranes for 2 hours before filtration over glass fiber filters. Each point represents the mean of three closely agreeing replicates. Opened and closed squares represent specific and nonspecific binding, respectively. Binding parameters were estimated by Scatchard plots shown as insets, and then fit to an untransformed single-site binding equation using a nonlinear least squares technique as described in Linden (1984) . Binding parameters fB»« fmol/mg protein; and K» nt4 were 585, 1.93, and 15.2, 11 .6 for brain and heart, respectively. Similar results were observed in two additional experiments. binding to heart membranes. [ i2i I]ABA (120 pM) and [™1]HPIA 045 pu) were incubated with the same preparation of rat ventricle membranes (460 ng) for 2 hours at 21°C The concentrations of both radioligands were less than 10% of their Ka in which case the ratio of specifically bound to free radioligand is proportional to the receptor affinity for the radioUgand. Since this ratio was approximately equal for both radioligands, we conclude that they have nearly identical Ko-In contrast, nonspecific f a I]HPIA binding was 6.2 times greater than nonspecific p a I]ABA binding. Data points represent the mean ± SEH n = 4. Figure 3 shows the results of [ 125 I]ABA equilibrium-binding assays to brain and heart membranes. Specific radioligand binding to heart membranes exceeded nonspecific binding at radioligand concentrations below its K D . [ 125 I]ABA bound with higher affinity to brain membranes (K D = 1.93 nM) than heart membranes (K D = 11.6 nM), possibly reflecting a difference in receptors. It is notable in this regard that [ 3 H]cydohexyladenosine binds with higher affinity to bovine (K D = 0.7 nM) than guinea pig brains 8.1 nu for brain and heart, respectively. Hill coefficients ranged  between 0.7 and 0.9 . Data points represent the mean ± SEH n = 3. /ml adenosine deaminase, 1 mu ascorbate, 1 muRo7-2956, and adenosine analogues without (top) or with (bottom) 1 IIMIisoproterenol for 90 seconds, and then lysed with HO (see Methods) . In the basal condition, 100% corresponds to 24 pmol/mg protein; in the l-isoproterenol-stimulated condition, 100% corresponds to 121 pmol/mg protein. Data points represent the mean ± sat n -4. Bruns et al., 1980) . The ability of PIA and 5'-A[-ethylcarboxamide adenosine (NECA) to compete with [ 12S I]ABA for binding to brain and heart membranes is illustrated in Figure 4 . In both cases, NECA was less potent than PIA, indicative of binding to R t receptors [Yeung and Green, 1983) .
Binding of [ 12J I]HPIA and [ 1M I]ABA to Heart Membranes
FIGURE 6. Effect of adenosine analogues on the cAMP content of adipocytes. Freshly prepared adipocytes (70 tig protein) were incubated with 1 U
The high affinity of [ lfc I]ABA for adenosine receptors was surprising in view of the relatively low affinity of N*-benzyladenosine compared to N-substituted isopropyl and phenyl compounds (Daly, 1982) . Displacement of [^IJHPIA by ABA or IABA from binding to brain membranes (Fig. 5) indicates that the iodinated compound has a much greater affinity for adenosine receptors in brain than the uniodinated compound. The increase in affinity upon iodination may be due to a steric or hydrophobic effect of the iodine atom.
Effect of ABA and IABA on Adipocyte and Heart Cell Cyclic AMP Content
The addition of three adenosine analogs, PIA, IABA, and ABA, to isolated adipocytes resulted in a 40 and 80% decrease, respectively, in the basal-and I-isoproterenol-stimulated cAMP content of isolated adipocytes (Fig. 6) . These experiments confirm that IABA is a full adenosine agonist with an efficacy equivalent to PIA. Also, as was the case in radioligand binding assays, IABA was found to be over 20 times more potent than ABA. PIA and IABA also decreased isoproterenol-stimulated cAMP accumulation in embryonic chick heart cells (Fig. 7) . The maximum response of heart cells to adenosine agonists, 30%, was considerably less than the maximum response in adipocytes. In the absence of isoproterenol, adenosine analogs has no detectable effect on the cAMP content of heart cells. Assays were conducted in the presence of 1 nun Ro7-2956 and 1 U/ Freshly prepared heart cells (89 fig  protein) were incubated with adenosine deaminase, ascorbate, Ro7-2956, and l-isoproterenol, as described in the legend for Figure 6 . Data points represent the mean ± SEM, n •= 5. ml of adenosine deaminase. cAMP levels for basal, PLA-treated (1 /*M for 90 seconds), and IABA-treated heart cells were 11.74 ± 0.39, 11.10 ± 0.37, and 12.17 ± 0.41 pmol/mg protein, respectively (mean ± SEM, n = 10).
Additional Uses of ["'TJABA
In brain and testes, the density of adenosine receptors is in excess of 1 pmol/g wet weight, and currently available radioligands are adequate for measuring Ri receptors. However, [ 125 I]ABA may represent an important improvement in detection of adenosine receptors in other tissues which contain fewer than 0.3 pmol/g wet weight of adenosine receptors. These include heart, lung, kidney, adrenal, fat, stomach, small intestine, pancreas, thyroid, skeletal muscle, vas deferens, ovary, and submandibular gland (Murphy and Snyder, 1981) .
